Samar Sadeghi

Potential Therapeutic Effects of Long-Term Stem Cell Administration: Impact on the Gene Profile and Kidney Function of PKD/Mhm (Cy/+) Rats

N. Gretz, C. Sticht, M. Keese, 2022, Journal of clinical medicine.

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

A. Kerstan, M. Jünger, G. Daeschlein, 2022, Stem Cell Research & Therapy.

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

A. Kerstan, Philipp Schrüfer, M. Goebeler, 2020, Cytotherapy.

Process data of allogeneic ex vivo-expanded ABCB5+ mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP

Julia Pieper, M. Frank, E. Niebergall-Roth, 2020, Stem cell research & therapy.

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

A. Kerstan, M. Jünger, G. Daeschlein, 2021, JID innovations.

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

S. Sel, B. Ksander, J. Chodosh, 2020, Stem cell research & therapy.

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, J. McGrath, C. Ebens, 2021, JCI insight.

Clinical trial of ABCB5 + mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, C. Ebens, A. Hovnanian, 2021 .